NO960332L - Tbp2 fragments of the transferrin receptor of neisseria meningitidis - Google Patents

Tbp2 fragments of the transferrin receptor of neisseria meningitidis

Info

Publication number
NO960332L
NO960332L NO960332A NO960332A NO960332L NO 960332 L NO960332 L NO 960332L NO 960332 A NO960332 A NO 960332A NO 960332 A NO960332 A NO 960332A NO 960332 L NO960332 L NO 960332L
Authority
NO
Norway
Prior art keywords
tbp2
neisseria meningitidis
transferrin receptor
fragments
tbp2 subunit
Prior art date
Application number
NO960332A
Other languages
Norwegian (no)
Other versions
NO960332D0 (en
Inventor
Marie-Jose Bernadette J Millet
Ling Lissolo
Veronique Mazarin
Michele Legrain
Eric Jacobs
Original Assignee
Pasteur Merieux Serums Vacc
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc, Transgene Sa filed Critical Pasteur Merieux Serums Vacc
Publication of NO960332D0 publication Critical patent/NO960332D0/en
Publication of NO960332L publication Critical patent/NO960332L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Polypeptid som har en aminosyresekvens som er avledet fra sekvensen til Tbp2 subenheten til transferrinreseptoren av en Neisseria meningitidis stamme av typen IM2169 eller IM2394, hvor første, andre og tredje domener er definert ved opp- stilling til maksimal homologi med Tbp2 subenhetssekvensen til henholdsvis IM2169 eller IM2394 referansestammen, særlig ved total eller delvis delesj on av minst ett domene i nevnte Tbp2 subenhet til IM2169 eller IM2394 typen, med den betingelse at det første og andre domenet ikke deleres fullstendig samtidig.A polypeptide having an amino acid sequence derived from the sequence of the Tbp2 subunit of the transferrin receptor of a Neisseria meningitidis strain of type IM2169 or IM2394, wherein first, second and third domains are defined by alignment to maximum homology with the Tbp2 subunit sequence9 or IM239, respectively. the reference strain, especially with total or partial deletion of at least one domain of said Tbp2 subunit of the IM2169 or IM2394 type, provided that the first and second domains are not completely shared at the same time.

NO960332A 1994-05-31 1996-01-26 Tbp2 fragments of the transferrin receptor of neisseria meningitidis NO960332L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9406594A FR2720408B1 (en) 1994-05-31 1994-05-31 Fragments Tbp2 of Neisseria meningitidis.
PCT/FR1995/000701 WO1995033049A2 (en) 1994-05-31 1995-05-30 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS

Publications (2)

Publication Number Publication Date
NO960332D0 NO960332D0 (en) 1996-01-26
NO960332L true NO960332L (en) 1996-03-21

Family

ID=9463680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960332A NO960332L (en) 1994-05-31 1996-01-26 Tbp2 fragments of the transferrin receptor of neisseria meningitidis

Country Status (9)

Country Link
EP (1) EP0720653A1 (en)
JP (1) JPH09501059A (en)
AU (1) AU706090B2 (en)
CA (1) CA2167936A1 (en)
FI (1) FI960428L (en)
FR (1) FR2720408B1 (en)
HU (1) HU220116B (en)
NO (1) NO960332L (en)
WO (1) WO1995033049A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739624B1 (en) * 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc NEW NEISSERIA MENINGITIDIS TBP2 SUBUNIT
US6440701B1 (en) 1996-03-08 2002-08-27 Aventis Pasteur Limited Transferrin receptor genes of Moraxella
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
FR2767060B1 (en) * 1997-08-07 2000-02-11 Pasteur Merieux Serums Vacc MENINGOCOCCAL VACCINE WITH BZ83 STRAIN VALENCE
BR9811907A (en) * 1997-08-15 2000-08-15 Univ Utrecht Neisseria lactoferrin binding protein
EP1047784B2 (en) * 1998-01-14 2015-03-18 Novartis Vaccines and Diagnostics S.r.l. Neissera meningitidis antigens
EP2261338A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
FR2785293B1 (en) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc NUCLEIC ACIDS AND POLYPEPTIDES SPECIFIC TO NEISSERIA PATHOGENIC STRAINS
US6391316B1 (en) 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
US7241449B1 (en) 1999-04-12 2007-07-10 Aventis Pasteur Limited Transferrin receptor genes of moraxella
WO2000066741A2 (en) 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens
NZ515935A (en) 1999-05-19 2004-01-30 Chiron S Combination Neisserial compositions and vaccines for the prevention of infections due to Neisseria bacteria such as meningococcal meningitis
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
NZ521531A (en) 2000-02-28 2005-12-23 Chiron S Heterologous expression of neisserial proteins
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
US9259462B2 (en) 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
AU2013276083B2 (en) 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682041B1 (en) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins VACCINE AGAINST NEISSERIA MENINGITIDIS INFECTIONS.
FR2682114B1 (en) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc SUB-UNIT VACCINE AGAINST NEISSERIA MENINGITIDIS AND SUB-UNITS CORRESPONDING TO PURIFIED STATE.
FR2692592B1 (en) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc DNA fragments encoding the Neisseria meningitidis transferrin receptor subunits and methods of expressing them.
EP0625165A1 (en) * 1992-08-31 1994-11-23 Global Tek, Inc. Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis

Also Published As

Publication number Publication date
FR2720408A1 (en) 1995-12-01
FI960428A0 (en) 1996-01-30
HU220116B (en) 2001-11-28
WO1995033049A2 (en) 1995-12-07
WO1995033049A3 (en) 1996-01-04
FI960428A7 (en) 1996-03-28
FI960428L (en) 1996-03-28
FR2720408B1 (en) 1996-08-14
AU2675795A (en) 1995-12-21
NO960332D0 (en) 1996-01-26
AU706090B2 (en) 1999-06-10
EP0720653A1 (en) 1996-07-10
JPH09501059A (en) 1997-02-04
HUT75992A (en) 1997-05-28
CA2167936A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
NO960332L (en) Tbp2 fragments of the transferrin receptor of neisseria meningitidis
MX2023000618A (en) ATTENTION-BASED NEURONAL NETWORK TO PREDICT PEPTIDE BINDING, PRESENTATION AND IMMUNOGENICITY.
NO953643L (en) New means of controlling cell activity
ES2176252T3 (en) BENZAMIDS REPLACED WITH FLUORO-ALCOXI AND ITS USE AS INHIBITING AGENTS OF PHOSPHODIESTERASES OF CYCLIC NUCLEOTIDES.
DK0695301T3 (en) Indole derivatives as 5-HT1-like agonists for use in migraine
NO951613L (en) Non-peptidyl tachykinin receptor antagonists
ATE213727T1 (en) IN POSITION 3 1,3-DIHYDROINDOL-2-ONE DERIVATIVES SUBSTITUTED BY A NITROGEN GROUP AS VASOPRESSIN AND/OR OCYTOCIN AGONISTS AND/OR ANTAGONISTS
MXPA04001974A (en) Soluble t cell receptor.
NO961683L (en) Multicore metallocene compound process for its preparation and its use as a catalyst
NO20063026L (en) antibodies
AR248045A1 (en) Recombinant avipox virus
DK0479948T3 (en) Compositions and Methods for the Synthesis of Natriuretic Protein Receptor B and Methods of Use
ATE481417T1 (en) MODIFIED AVIDIN AND STREPTAVIDIN AND METHODS OF USE THEREOF
NO20081654L (en) Stabilized GLP-1 analogs
ATE175119T1 (en) VACCINE AGAINST CAT IMMUNODEFICIENCY VIRUS (KIV)
NO972314L (en) Neisseria meningitidis TBP2 subunit
DK0674716T3 (en) Retroviral vectors for the treatment of tumors and cell lines containing them
EP0813416A4 (en) REDUCTION INFECTIVE AMOUNT USING CITICOLIN
DE59401730D1 (en) BUFFERED DC VOLTAGE SYSTEM
NO862383D0 (en) CLONING OR EXIT VECTORS COMPREHENSIVE THROUGH THE VIRUS OF ERYTHROBLASTOSE AND CELLS MODIFIED BY THE VECTORS.
DE69227984D1 (en) Vaccine containing a subunit of the Neisseria meningitidis human transferrin receptor
DE59105636D1 (en) Expression of HIV1 and 2 polypeptides and their use.
ES8500995A1 (en) A PROCEDURE FOR THE PREPARATION OF A RECOMBINANT DNA CLONING VECTOR.
NO20083576L (en) Peptides of regulatory or auxiliary proteins of HIV, as well as compositions and uses thereof
GB1143588A (en)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application